Taltz in the real-world: Month12 out comes from the PSoHO study.

0 SAR
Checkout

Overview

New real-world data from and see how and how the results align with what patients with moderate to severe plaque psoriasis want.


This Class for

  • Physician
  • Resident / Fellow

What I will learn?

  • To reinforce the efficacy of Taltz and how it aligns with patients' needs.




    Disclaimer

    This content is approved by Eli Lilly and Company (“Lilly”). This content is intellectual property of Lilly and its reproduction needs Lilly's prior permission
    (This information/content is intended to Health Care Providers only)

    For adverse events and safety reporting: email: saudi_pharmacovigilance@lilly.com
    24 /7 mobile : +966 567 868 843 working hours: +966 11 461 7800 , Ext: 1
    For Lilly product information: email: SAUDI_MEDINFOQUERIES@lilly.com
    For further information, please contact:
    Eli Lilly and Company, Scientific Office P.O. Box 92120 Riyadh 11653, Kingdom of Saudi Arabia. Tel: +966 11 461 7800 Fax: +966 111 217 9900 email: Saudi_Pharmacovigilance@lilly.com

    Please go to PDF Material for prescribing information


    PP-IX-SA-1031


Related Classes